Educational purposes only. Not investment advice. Past performance does not guarantee future results. View full terms

JNJ

Johnson & Johnson β€’ Healthcare (#5 of 11)

$244.02
-0.42 (-0.17%)
View:
Close:$244.02
Vol:LOW(10%ile)
Ratio:0.78x
|
RSI:60(Neutral)
MACD:↑
β‰₯75%25-75%<25%
Vol.%
Sector Rotation
2026-04-01(10/10)
20d Strength (bar)
Strong (Β±4%)
Normal (-2~+3%)
5d Strength (normal: -1~+1%)
Relative Strength Trajectory
5d Strength
10d Strength
20d Strength
NASDAQ
10d early: 3~5%|20d confirm: 4~8.5%|>8.5% exhaustion
Analyst Actions
NEUTRAL
β–²0 Upβ–Ό0 Down5 Hold
Mar 30RBC Capital
–Outperform
Mar 19Barclays
–Equal-Weight
Mar 17HSBC
–Buy
Mar 11Citigroup
–Buy
Mar 5JP Morgan
–Neutral
Price Targets
(60d mean: $259, +6.0%)
NEUTRAL
β–²4 Raisesβ–Ό0 Lowers+8.6% avg
Mar 30RBC Capital
$255β†’$255New
Mar 19Barclays
$217β†’$234+7.8%
Mar 17HSBC
$265β†’$280+5.7%
Mar 11Citigroup
$250β†’$274+9.6%
Mar 5JP Morgan
$225β†’$250+11.1%
Trade Setup
Entry$244.02
Target$251.98 (+3.3%)
Stop$236.06
R/R1.00
Risk-3.3%
Conv37 (LOW)
Size55 shares ($13,421)
Risk Metrics
Sharpe (20d)
-0.35Losing
Volatility (20d)
15.6%Low
Beta (60d)
0.05Defensive
Alpha (20d)
+3.7%Moderate+
News Analysis
EN
δΈ­
ν•œ
ζ—₯

No analysis record found.